![](https://ml-eu.globenewswire.com/media/f164672f-d67c-41d2-9c79-46caee419077/small/logo-pharming-original-png.png)
Pharming Group reports second quarter and first half 2024 financial results and provides business update
Second quarter 2024 total revenues increased by 35% to US$74.1 million, compared to the second quarter 2023, driven by strong RUCONEST® and Joenja® revenue growth RUCONEST® second quarter revenue increased by 23% to US$63.0 million, compared to the second …